Status:
TERMINATED
IL-26 and Systemic Lupus Erythematosus
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Diagnosis of Lupus According to ACR criteriaAgreement for the Blood Sampling
Eligibility:
All Genders
18+ years
Brief Summary
Treatment of multisystemic forms of lupus displays severe side effects and limited efficacy, underscoring the need to better dissection of the pathogenic mechanisms. Concordant with preliminary data, ...
Eligibility Criteria
Inclusion
- diagnostic of Lupus according to ACR criteria ( four criteria are necessary)
- age \> 18 years old
Exclusion
- treatment by cyclophosphamide, rituximab, belimumab in the year before inclusion study
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01889641
Start Date
February 1 2014
End Date
April 1 2015
Last Update
September 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, Bas Rhin, France, 67091